Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited) - USD ($)
|
Preferred Stock [Member]
Series A Preferred Stock [Member]
|
Preferred Stock [Member]
Series B Preferred Stock [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Stock Payable [Member] |
Subscription Receivable [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Total |
Beginning balance, value at Mar. 31, 2021 |
$ 500
|
|
$ 56,075
|
$ 56,649,491
|
$ 136,000
|
|
$ (53,683,268)
|
$ (87,830)
|
$ 3,070,969
|
Beginning balance, shares at Mar. 31, 2021 |
5,000,000
|
607
|
560,745,180
|
|
|
|
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
|
|
|
3,269,505
|
|
|
|
|
3,269,505
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(817,376)
|
|
(817,376)
|
Common stock vested to consultants |
|
|
$ 13
|
48,738
|
24,900
|
|
|
|
73,651
|
Common stock vested to consultants, shares |
|
|
125,000
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(2,562,743)
|
|
(2,562,743)
|
Issuance of common stock upon conversion |
|
|
$ 133
|
421,353
|
|
|
|
|
421,486
|
Issuance of common stock upon conversion, shares |
|
|
1,329,246
|
|
|
|
|
|
|
Conversion of Series B Preferred Shares to common stock |
|
|
$ 314
|
(314)
|
|
|
|
|
|
Conversion of Series B Preferred Shares to common stock, shares |
|
(262)
|
3,144,000
|
|
|
|
|
|
|
Conversion of Series D PS to common stock |
|
|
$ 43
|
(43)
|
|
|
|
|
|
Conversion of Series D PS to common stock, shares |
|
|
428,572
|
|
|
|
|
|
|
Exchange of Series D Preferred Shares to Series E Preferred Shares |
|
|
|
|
|
|
(3,258,189)
|
|
(3,258,189)
|
Sale of common shares and warrants for cash, less offering costs and commitment shares |
|
|
$ 3,577
|
17,273,546
|
|
|
|
|
17,277,123
|
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares |
|
|
35,772,729
|
|
|
|
|
|
|
Exercise of warrants related to the sale of common shares |
|
|
$ 110
|
10,890
|
|
|
|
|
11,000
|
Exercise of warrants related to the sale of common shares, shares |
|
|
1,100,000
|
|
|
|
|
|
|
Redemption of Series D Preferred shares |
|
|
|
|
|
|
(2,534,758)
|
|
(2,534,758)
|
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity |
|
|
|
(3,087,830)
|
2,000,000
|
|
|
87,830
|
(1,000,000)
|
Common shares to be issued for Patent acquisition |
|
|
|
|
5,000,000
|
|
|
|
5,000,000
|
Ending balance, value at Jun. 30, 2021 |
$ 500
|
|
$ 60,265
|
74,585,336
|
7,160,900
|
|
(62,856,334)
|
|
18,950,668
|
Ending balance, shares at Jun. 30, 2021 |
5,000,000
|
345
|
602,644,727
|
|
|
|
|
|
|
Beginning balance, value at Mar. 31, 2021 |
$ 500
|
|
$ 56,075
|
56,649,491
|
136,000
|
|
(53,683,268)
|
(87,830)
|
3,070,969
|
Beginning balance, shares at Mar. 31, 2021 |
5,000,000
|
607
|
560,745,180
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
(38,778,923)
|
Ending balance, value at Dec. 31, 2021 |
$ 500
|
|
$ 64,183
|
86,808,594
|
29,524,000
|
|
(101,798,974)
|
|
14,597,966
|
Ending balance, shares at Dec. 31, 2021 |
5,000,000
|
67
|
641,722,043
|
|
|
|
|
|
|
Beginning balance, value at Jun. 30, 2021 |
$ 500
|
|
$ 60,265
|
74,585,336
|
7,160,900
|
|
(62,856,334)
|
|
18,950,668
|
Beginning balance, shares at Jun. 30, 2021 |
5,000,000
|
345
|
602,644,727
|
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
|
$ 411
|
(411)
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock, shares |
|
|
4,114,286
|
|
|
|
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(1,341,948)
|
|
(1,341,948)
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(177,586)
|
|
(177,586)
|
Common stock vested to consultants |
|
|
$ 6
|
24,369
|
24,900
|
|
|
|
49,275
|
Common stock vested to consultants, shares |
|
|
62,500
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(2,849,635)
|
|
(2,849,635)
|
Revision of dividends payable on Series B Preferred Shares (See Note 2) |
|
|
|
|
|
|
(182,639)
|
|
(182,639)
|
Common shares issued for Technical and Equipment Rights Agreement |
|
|
|
|
4,762,376
|
|
|
|
4,762,376
|
Ending balance, value at Sep. 30, 2021 |
$ 500
|
|
$ 60,683
|
74,609,294
|
11,948,176
|
|
(67,408,142)
|
|
19,210,511
|
Ending balance, shares at Sep. 30, 2021 |
5,000,000
|
345
|
606,821,513
|
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
|
$ 411
|
2,879,589
|
|
|
|
|
2,880,000
|
Conversion of Series E Preferred Shares to common stock, shares |
|
|
4,114,286
|
|
|
|
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
|
|
|
169,714
|
|
|
|
|
169,714
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(831,543)
|
|
(831,543)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
|
(80,167)
|
|
(80,167)
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(112,577)
|
|
(112,577)
|
Common stock vested to consultants |
|
|
$ 21
|
99,054
|
(49,800)
|
|
|
|
49,275
|
Common stock vested to consultants, shares |
|
|
112,500
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(33,366,545)
|
|
(33,366,545)
|
Conversion of Series B Preferred Shares to common stock |
|
|
$ 334
|
(334)
|
|
|
|
|
(334)
|
Conversion of Series B Preferred Shares to common stock, shares |
|
(278)
|
3,336,000
|
|
|
|
|
|
|
Common shares issued for Technical and Equipment Rights Agreement |
|
|
$ 2,673
|
11,759,706
|
(11,762,376)
|
|
|
|
|
Common shares issued for Technical and Equipment Rights Agreement, shares |
|
|
26,732,673
|
|
|
|
|
|
|
Common stock issued to consultants |
|
|
$ 43
|
158,285
|
|
|
|
|
158,328
|
Common stock issued to consultants, shares |
|
|
430,071
|
|
|
|
|
|
|
Common stock vested to employees |
|
|
$ 18
|
68,286
|
|
|
|
|
68,304
|
Common stock vested to employees, shares |
|
|
175,000
|
|
|
|
|
|
|
Reclassification of warrants to liability |
|
|
|
(2,935,000)
|
|
|
|
|
(2,935,000)
|
Common stock to be issued for legal settlement to NSH shareholders |
|
|
|
|
29,388,000
|
|
|
|
29,388,000
|
Ending balance, value at Dec. 31, 2021 |
$ 500
|
|
$ 64,183
|
86,808,594
|
29,524,000
|
|
(101,798,974)
|
|
14,597,966
|
Ending balance, shares at Dec. 31, 2021 |
5,000,000
|
67
|
641,722,043
|
|
|
|
|
|
|
Beginning balance, value at Mar. 31, 2022 |
$ 500
|
|
$ 67,500
|
96,701,607
|
20,132,650
|
|
(150,036,023)
|
|
(33,133,766)
|
Beginning balance, shares at Mar. 31, 2022 |
5,000,000
|
|
674,644,124
|
|
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders |
|
|
$ 6,112
|
19,311,486
|
(19,317,598)
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders, shares |
|
|
61,154,136
|
|
|
|
|
|
|
Conversion of Series E Preferred Shares to common stock |
|
|
$ 454
|
839,546
|
|
|
|
|
840,000
|
Conversion of Series E Preferred Shares to common stock, shares |
|
|
4,537,240
|
|
|
|
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
|
|
|
99,000
|
|
|
(99,000)
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(42,500)
|
|
(42,500)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
|
(278,500)
|
|
(278,500)
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(102,227)
|
|
(102,227)
|
Common stock issued in business agreement |
|
|
$ 25
|
56,225
|
|
(56,250)
|
|
|
|
Common stock issued in business agreement ,shares |
|
|
250,000
|
|
|
|
|
|
|
Common stock vested to consultants |
|
|
$ 6
|
24,369
|
|
|
|
|
24,375
|
Common stock vested to consultants, shares |
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(2,200,176)
|
|
(2,200,176)
|
Ending balance, value at Jun. 30, 2022 |
$ 500
|
|
$ 74,097
|
117,032,233
|
815,052
|
(56,250)
|
(152,758,426)
|
|
(34,892,794)
|
Ending balance, shares at Jun. 30, 2022 |
5,000,000
|
|
740,585,500
|
|
|
|
|
|
|
Beginning balance, value at Mar. 31, 2022 |
$ 500
|
|
$ 67,500
|
96,701,607
|
20,132,650
|
|
(150,036,023)
|
|
(33,133,766)
|
Beginning balance, shares at Mar. 31, 2022 |
5,000,000
|
|
674,644,124
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
|
(11,552,820)
|
Increase of 10% in Series E Preferred Shares to one holder based on certain rights |
|
|
|
|
|
|
|
|
156,000
|
Ending balance, value at Dec. 31, 2022 |
$ 500
|
|
$ 76,894
|
119,464,471
|
662,767
|
(56,250)
|
(163,037,985)
|
|
(42,889,603)
|
Ending balance, shares at Dec. 31, 2022 |
5,000,000
|
|
768,561,129
|
|
|
|
|
|
|
Beginning balance, value at Jun. 30, 2022 |
$ 500
|
|
$ 74,097
|
117,032,233
|
815,052
|
(56,250)
|
(152,758,426)
|
|
(34,892,794)
|
Beginning balance, shares at Jun. 30, 2022 |
5,000,000
|
|
740,585,500
|
|
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders |
|
|
$ 40
|
127,646
|
(127,686)
|
|
|
|
|
Common stock issued for legal settlement to NSH shareholders, shares |
|
|
404,067
|
|
|
|
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(42,500)
|
|
(42,500)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
|
(278,500)
|
|
(278,500)
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(55,427)
|
|
(55,427)
|
Common stock issued in business agreement |
|
|
$ 25
|
25,975
|
|
|
|
|
26,000
|
Common stock issued in business agreement ,shares |
|
|
250,000
|
|
|
|
|
|
|
Common stock vested to consultants |
|
|
$ 6
|
24,369
|
|
|
|
|
24,375
|
Common stock vested to consultants, shares |
|
|
62,500
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
(24,528,345)
|
|
(24,528,345)
|
Conversion of Series E Preferred Shares to common stock |
|
|
$ 992
|
827,008
|
|
|
(108,000)
|
|
720,000
|
Conversion of Series E Preferred Shares to common stock, shares |
|
|
9,920,887
|
|
|
|
|
|
|
Increase of 10% in Series E Preferred Shares to one holder based on certain rights |
|
|
|
|
|
|
(156,000)
|
|
(156,000)
|
Common stock issued from shares payable |
|
|
$ 10
|
24,590
|
(24,600)
|
|
|
|
|
Common stock issued from shares payable, shares |
|
|
100,000
|
|
|
|
|
|
|
Ending balance, value at Sep. 30, 2022 |
$ 500
|
|
$ 75,170
|
118,061,820
|
662,767
|
(56,250)
|
(177,927,198)
|
|
(59,183,191)
|
Ending balance, shares at Sep. 30, 2022 |
5,000,000
|
|
751,322,954
|
|
|
|
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
|
|
|
|
|
|
(28,048)
|
|
(28,048)
|
Accretion of Series E Preferred Shares |
|
|
|
|
|
|
(198,333)
|
|
(198,333)
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(60,107)
|
|
(60,107)
|
Common stock vested to consultants |
|
|
$ 6
|
24,369
|
|
|
|
|
24,375
|
Common stock vested to consultants, shares |
|
|
62,500
|
|
|
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
15,175,701
|
|
15,175,701
|
Issuance of common shares under financing agreement |
|
|
$ 1,718
|
1,378,282
|
|
|
|
|
1,380,000
|
Issuance of common shares under financing agreement, shares |
|
|
17,175,675
|
|
|
|
|
|
|
Ending balance, value at Dec. 31, 2022 |
$ 500
|
|
$ 76,894
|
$ 119,464,471
|
$ 662,767
|
$ (56,250)
|
$ (163,037,985)
|
|
$ (42,889,603)
|
Ending balance, shares at Dec. 31, 2022 |
5,000,000
|
|
768,561,129
|
|
|
|
|
|
|